[The use of perftoran for the lengthening of the period of tolerance to the experimental acute lethal hypoxia (the apnea model)].
Skorik
V I
VI
Shilov
V V
VV
Sudus
A V
AV
Zuev
V V
VV
D000818:Animals; D001049:Apnea / Q000150:complications / Q000503:physiopathology*; D001784:Blood Gas Analysis; D001802:Blood Substitutes / Q000494:pharmacology*; D004285:Dogs; D015199:Extracorporeal Membrane Oxygenation; D005260:Female; D005466:Fluorocarbons / Q000494:pharmacology*; D006438:Hemodilution; D006439:Hemodynamics / Q000187:drug effects; D000860:Hypoxia / Q000209:etiology / Q000503:physiopathology*; D008297:Male; D012121:Respiration, Artificial
D001802:Blood Substitutes; D005466:Fluorocarbons; C063334:perftoran